Cardinal Health, Inc.
240.00USD
-0.4900 (-0.20%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.94▲ | $2.9 | 4 | 3 |
| Next quarter | $3.11▲ | $2.98 | 7 | 0 |
| Current year | $12.57▲ | $11.99 | 16 | 0 |
| Next year | $14.08▲ | $13.52 | 12 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.42 | $2.6 | +0.18 (+7.4%) |
| 2026-03-31 | $2.79 | $3.17 | +0.38 (+13.7%) |
| 2025-12-31 | $2.37 | $2.63 | +0.26 (+11.2%) |
| 2025-09-30 | $2.17 | $2.55 | +0.38 (+17.6%) |
255 ratings from 31 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Initiated | Outperform | $276 | Aug 19, 2026 |
| TD Cowen | Maintained | Buy | $275 $280 | Aug 13, 2026 |
| JP Morgan | Maintained | Neutral | $215 $260 | Aug 13, 2026 |
| Barclays | Maintained | Overweight | $258 $275 | Aug 13, 2026 |
| Citigroup | Maintained | Buy | $265 $280 | Aug 12, 2026 |
| Evercore ISI Group | Maintained | Outperform | $265 $270 | Aug 12, 2026 |
| Morgan Stanley | Maintained | Overweight | $255 $265 | Aug 12, 2026 |
| Mizuho | Maintained | Outperform | $240 $250 | Aug 12, 2026 |
| UBS | Maintained | Buy | $274 $280 | Aug 12, 2026 |
| Wells Fargo | Maintained | Overweight | $245 $277 | Aug 12, 2026 |
| Baird | Maintained | Outperform | $251 $274 | Aug 12, 2026 |
| Citigroup | Maintained | Buy | $245 $265 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $235 $240 | Jul 23, 2026 |
| UBS | Maintained | Buy | $260 $274 | Jul 20, 2026 |
| TD Cowen | Maintained | Buy | $255 $275 | Jul 9, 2026 |
| B of A Securities | Maintained | Buy | $240 $260 | Jul 2, 2026 |
| JP Morgan | Maintained | Neutral | $243 $215 | May 4, 2026 |
| Citigroup | Maintained | Buy | $249 $245 | May 1, 2026 |
| TD Cowen | Maintained | Buy | $251 $255 | May 1, 2026 |
| Wells Fargo | Maintained | Overweight | $256 $245 | May 1, 2026 |
| William Blair | Initiated | Outperform | — | Apr 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $260 $240 | Apr 8, 2026 |
| Barclays | Maintained | Overweight | $243 $258 | Feb 24, 2026 |
| JP Morgan | Maintained | Neutral | $209 $243 | Feb 10, 2026 |
| Wells Fargo | Maintained | Overweight | $237 $256 | Feb 10, 2026 |
76 filings from 20 insiders · 17 buy / 7 sell over 6m
Officers and directors of CAH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SCHERER MARY COfficer | Sell | 2.3k | $237.39 | $546k | Aug 19, 2026 |
| HOLLAR JASON MChief Executive Officer | Sell | 124.5k | $233.22 | $29.38M | Aug 19, 2026 |
| MAYER JESSICA L.Officer | Sell | 29.4k | $234.64 | $6.95M | Aug 18, 2026 |
| ALT AARON E.Chief Financial Officer | Sell | 42.0k | $234.55 | $9.93M | Aug 18, 2026 |
| MASON STEPHEN MOfficer | Sell | 35.0k | $234.59 | $8.27M | Aug 18, 2026 |
| GREENE MICHELLE DChief Technology Officer | Sell | 11.7k | $234.57 | $2.75M | Aug 18, 2026 |
| WEITZMAN DEBORAHOfficer | Sell | 7.4k | $235.30 | $1.73M | Aug 18, 2026 |
| ALT AARON E.Chief Financial Officer | Grant | 8.1k | — | — | Aug 14, 2026 |
| HOLLAR JASON MChief Executive Officer | Grant | 30.6k | — | — | Aug 14, 2026 |
| SCHERER MARY COfficer | Grant | 765 | — | — | Aug 14, 2026 |
| WEITZMAN DEBORAHOfficer | Grant | 7.3k | — | — | Aug 14, 2026 |
| PITTEROFF VALERIE CHRISTINEOfficer | Grant | 3.0k | — | — | Aug 14, 2026 |
| MAYER JESSICA L.Officer | Grant | 6.4k | — | — | Aug 14, 2026 |
| MASON STEPHEN MOfficer | Grant | 5.9k | — | — | Aug 14, 2026 |
| GREENE MICHELLE DChief Technology Officer | Grant | 2.6k | — | — | Aug 14, 2026 |
| ALT AARON E.Chief Financial Officer | Grant | 58.7k | — | — | Aug 4, 2026 |
| HOLLAR JASON MChief Executive Officer | Grant | 188.0k | — | — | Aug 4, 2026 |
| SCHERER MARY COfficer | Grant | 2.6k | — | — | Aug 4, 2026 |
| WEITZMAN DEBORAHOfficer | Grant | 54.8k | — | — | Aug 4, 2026 |
| PITTEROFF VALERIE CHRISTINEOfficer | Grant | 2.6k | — | — | Aug 4, 2026 |
No analyst notes on CAH yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 12 | 3 | 0 | 0 | Buy2.00 |
| 1 mo ago | 2 | 12 | 3 | 0 | 0 | Buy2.06 |
| 2 mo ago | 2 | 12 | 3 | 0 | 0 | Buy2.06 |